Famotidine FCT + Famotidine CT
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
Aug 1, 2006 → Sep 1, 2006
NCT ID
NCT00945750About Famotidine FCT + Famotidine CT
Famotidine FCT + Famotidine CT is a phase 1 stage product being developed by Merck for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00945750. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00945750 | Phase 1 | Completed |
Competing Products
20 competing products in Heartburn